Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01466491 · ClinicalTrials.gov registry record · Phase 4
Refining Paracervical Block Techniques for Pain Control in First Trimester Surgical Abortion
A Phase 4 study, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- Phase 4
- Development phase
- 332
- Enrollment target
NCT01466491: Completed Phase 4 study, sponsored by Oregon Health and Science University.
NCT01466491 is a Phase 4 study that has completed, run by Oregon Health and Science University. The registered enrollment target is 332 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (36% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01466491, a Phase 4 study, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 332 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the level of pain women experience with a surgical abortion and the effect that varying paracervical block techniques might have on that pain. These different techniques involve wait time following the injection as well as the number of sites injected.
Primary Outcome
To determine whether varying paracervical block techniques affect patient perception of pain. Pain is measured as mm distance from the left of the 100-mm visual analogue (VAS) scale with the anchors 0 = none, 100 mm = worst imaginable (reflecting magnitude of pain) and recorded immediately after completion of cervical dilation.
Interventions
- DRUG Paracervical block technique with lidocaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 332 participants |
| Start Date | 2011-10 |
| Est. Completion | 2013-05 |
| Phase | Phase 4 |
What the finished NCT01466491 record still lists
NCT01466491 is an interventional study that assigns participants to a tested intervention. The registered 332 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (36% lower).
The record links to 0 conditions, and to 1 intervention - of which Paracervical block technique with lidocaine is the first listed.
NCT01466491 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01466491 about?
NCT01466491 is a clinical study titled "Refining Paracervical Block Techniques for Pain Control in First Trimester Surgical Abortion". The purpose of this study is to determine the level of pain women experience with a surgical abortion and the effect that varying paracervical block techniques might have on that pain. These different techniques involve wait time following the injection as well as the number of sites injected.
What is the current status of trial NCT01466491?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 332 participants. The study started on 2011-10. Estimated completion is 2013-05.
What interventions are being tested in trial NCT01466491?
The interventions under investigation include: Paracervical block technique with lidocaine (DRUG).
Who is sponsoring clinical trial NCT01466491?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01466491's enrollment target sits among peer trials
332 253rd of 2000 higher than 1,748 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174121 · 332 participants · Phase 2
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
- NCT02605785 · 332 participants · NA
A Molecular Anatomic Imaging Analysis of Tau in Progressive Supranuclear Palsy
- NCT04894006 · 332 participants · NA
Dementia Family Caregiver Study
- NCT05130606 · 332 participants · NA
CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia